Nocturnal sleep-disturbing nicotine craving and accomplishment with a smoking cessation program
- PMID: 19225735
- DOI: 10.1007/s10354-008-0640-x
Nocturnal sleep-disturbing nicotine craving and accomplishment with a smoking cessation program
Abstract
Aims: To study nocturnal sleep-disturbing nicotine craving (NSDNC), described as a symptom of nicotine dependence, in 2884 patients.
Methods: All patients were part of a smoking cessation program of the Nicotine Institute in collaboration with the general sick fund of Lower Austria. During the study period, the program (which is ongoing) lasted five weeks and included individual counseling. At all appointments, patients received a questionnaire about smoking habits, illnesses, previous experience in smoking cessation and their motivation to complete the program with the help of an assistant. Carbon monoxide levels in expired air were also measured.
Results: Analysis of NSDNC showed that 22.4% (n = 647) of patients suffered from this symptom with varying intensity: 77.1% (n = 499) awoke rarely; 9.4% (n = 61) awoke several times per week; 6.8% (n = 44) awoke most days and 6.6% (n = 43) awoke daily. NSDNC was associated with nicotine dependence, the number of cigarettes smoked per day, CO level and the craving for cigarettes in general. Consequences for smoking cessation programs are complex. Success rates were influenced by the intensity of NSDNC. Patients who awoke most days or daily had the lowest chance to quit smoking and the lowest compliance with the program.
Conclusions: Patients suffering from NSDNC, especially those who awoke most days or daily, formed a specific group among cigarette smokers. They can be classified as highly dependent smokers who have special needs regarding treatment strategies and medication. Further developments of specific cessation programs and strategies of tobacco harm reduction are recommended.
Similar articles
-
Nocturnal sleep-disturbing nicotine craving: a newly described symptom of extreme nicotine dependence.Acta Med Austriaca. 2001;28(1):21-2. doi: 10.1046/j.1563-2571.2001.01005.x. Acta Med Austriaca. 2001. PMID: 11253627
-
[Outpatient smoking cessation: a report on 3,260 cases].Wien Med Wochenschr. 2009;159(1-2):40-6. doi: 10.1007/s10354-008-0639-3. Wien Med Wochenschr. 2009. PMID: 19225734 German.
-
Predicting smoking cessation. Who will quit with and without the nicotine patch.JAMA. 1994 Feb 23;271(8):589-94. doi: 10.1001/jama.271.8.589. JAMA. 1994. PMID: 8301790 Clinical Trial.
-
Clinical efficacy of bupropion in the management of smoking cessation.Drugs. 2002;62 Suppl 2:25-35. doi: 10.2165/00003495-200262002-00003. Drugs. 2002. PMID: 12109933 Review.
-
Bupropion sustained release and smoking cessation.J Clin Psychiatry. 1998;59 Suppl 4:66-72. J Clin Psychiatry. 1998. PMID: 9554323 Review.
Cited by
-
[Smoking].Wien Med Wochenschr. 2009;159(1-2):1-3. doi: 10.1007/s10354-008-0633-9. Wien Med Wochenschr. 2009. PMID: 19225728 German. No abstract available.
-
Using ecological momentary assessment to assess the temporal relationship between sleep quality and cravings in individuals recovering from substance use disorders.Addict Behav. 2018 Aug;83:95-101. doi: 10.1016/j.addbeh.2017.11.001. Epub 2017 Nov 12. Addict Behav. 2018. PMID: 29137841 Free PMC article.
-
Why do cancer patients smoke and what can providers do about it?Community Oncol. 2012 Nov 1;9(11):344-352. doi: 10.1016/j.cmonc.2012.10.003. Epub 2012 Nov 17. Community Oncol. 2012. PMID: 23175636 Free PMC article.
-
Efficacy of Resistance Training as an Aid to Smoking Cessation: Rationale and Design of the Strength To Quit Study.Ment Health Phys Act. 2014 Jun 1;7(2):95-103. doi: 10.1016/j.mhpa.2014.05.004. Ment Health Phys Act. 2014. PMID: 25157265 Free PMC article.
-
The Interactions between Smoking and Sleep.Biomedicines. 2024 Aug 5;12(8):1765. doi: 10.3390/biomedicines12081765. Biomedicines. 2024. PMID: 39200229 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical